Health and Medicine

News about UB’s health sciences programs and related community outreach. (see all topics)

  • Cocaine Use, Hypertension Major Risk Factors For Brain Hemorrhage in Young African Americans, Study Finds
    7/8/01
    Young African Americans who use cocaine are six times more likely to suffer a potentially lethal episode of bleeding inside the brain than non-users, a case-control study of major risk factors for intracerebral hemorrhage in this population conducted by researchers at the University of Buffalo and Emory University has found.
  • "Alarming" Lack of Effort to Prevent Second Heart Attack or Stroke Found by UB Researchers
    6/27/01
    With mortality looming, people who have survived one heart attack or stroke would do everything possible to avoid a second. Right? Wrong. A study conducted by researchers at the University at Buffalo using information from a national population-based database, indicates there is "an alarming magnitude of inadequate secondary prevention in the U.S. population."
  • Avandia® May Reduce Risk of Cardiovascular Disease
    6/26/01
    The oral anti-diabetes drug Avandia® (rosiglitazone maleate) may decrease the risk of cardiovascular disease, the leading cause of death in the United States, according to data presented at the American Diabetes Association's 61st Scientific Sessions.
  • Drinking Alcohol Daily and Without Meals Is Associated with Increased Risk of Hypertension, UB Study Finds
    6/13/01
    If you are a drinker, when and in what situations you drink may affect your blood pressure, findings of a University at Buffalo study presented at the Society for Epidemiology Research have shown.
  • New Wireless Architecture Would Extend Cell-Phone Coverage to Where It Is Needed Most
    6/12/01
    A new architecture for next-generation wireless systems for cellular phones proposed by University at Buffalo researchers could provide an efficient and flexible way to extend outdoor coverage, as well as provide indoor coverage, without building additional cellular phone towers.
  • Dietary Study Finds Marijuana Users Have Normal Nutritional Status, Risky Lifestyle Habits
    6/11/01
    Smoking marijuana and "the munchies" go together like ham and eggs in anecdotal popular culture. But how do marijuana users fare nutritionally in their everyday lives? Data from the Third National Health and Nutrition Examination Survey (NHANES III), analyzed by University at Buffalo researchers, paint a mixed nutritional picture.
  • Program Lists UB Events Marking Pan-Am Centennial
    6/8/01
    Free lectures on hygienic cookery. Demonstrations in wireless telegraphy. Visits to heaven and hell for 25 cents, with a trip to the moon at half price. Moving pictures or ostrich-watching, a dime apiece. Just as the Pan-American Exposition brought its patrons daily programs to keep them current on activities and exhibits -- the aforementioned activities took place on Oct. 19, 1901 -- so, too, is the University at Buffalo, which has published a souvenir program marking "UB Pan-Am 2001 Days."
  • The Sports World Wrongly Empowers Male Athletes at Great Expense to Women, Says UB Sports Historian
    6/6/01
    The past few decades seem to have marked a sea of change in public regard for female athletes. Does this signal a broader social definition of what it is to be female and feminine in American society? Emphatically no, says Susan Cahn, a distinguished and widely published scholar of sports history at the University at Buffalo.
  • Alcohol Consumption and Marriage: A Good Mix?
    6/6/01
    Alcohol's impact on marriage -- for better or for worse -- is the focus of a study being conducted by a research scientist at the University at Buffalo's Research Institute on Addictions (RIA) under a new $1.5 million grant from the National Institute on Alcohol Abuse and Alcoholism.
  • 12-Hour ADHD Drug as Effective as Thrice Daily Doses
    6/4/01
    A new 12-hour formulation of the most commonly prescribed drug for attention-deficit/hyperactivity disorder, or ADHD, has proved to be as effective as the standard three-times-a-day dosing regimen, a clinical trial conducted by University at Buffalo researchers has shown.